By Safura Abdool KarimDec. 18, 2020
Within the span of 10 days, regulators in the United Kingdom and the United States granted emergency use authorization for the Covid-19 vaccine made by Pfizer and BioNTech.
This vaccine, reported to be 95% effective, is now being rolled out across both
countries. And as I write this, the U.S. is poised to approve a second Covid-19 vaccine, this one made by Moderna.
Advertisement
It will likely take far longer for this vaccine to be available in sub-Saharan Africa, partly because its use was approved with emergency use authorizations instead of the developers pursing full licenses.
Previous efforts to expedite Covid-19 vaccine approval, such as Operation Warp Speed, were met with concerns about safety. In response, the largest vaccine developers pledged to submit their vaccine candidates for approval only after passing Phase 3 trials showed a vaccine’s effectiveness.
However, after early results of the Pfizer/BioNTech vaccine candidate trial [...]
DISCLAIMER
All news articles are shared for educational purposes only. The news content is hosted on the external news website. News articles titles are derived from the original news title, news content, dialogue, speech or general content theme. The news title may be edited and optimized for SEO, keyword density, information and internal website search purposes. You are advised to view the original news article for a better understanding. If you spot any mistakes, errors or omissions kindly contact us.